Drug Profile
Ceftizoxime alapivoxil
Alternative Names: AS 924; KY 020Latest Information Update: 06 Mar 2008
Price :
$50
*
At a glance
- Originator Kyoto Pharmaceutical Industries
- Developer Asahi Kasei
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 06 Mar 2008 Discontinued - Preregistration for Bacterial infections in Japan (PO)
- 12 Jul 2007 Development of this compound is ongoing
- 05 Nov 2003 Preregistration for Bacterial infections in Japan (PO)